Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases

被引:0
|
作者
Bernath-Nagy, Dominika [1 ,2 ]
Kalinyaprak, Melek Suekran [2 ]
Giannitsis, Evangelos [2 ]
Abraham, Pal [1 ]
Leuschner, Florian [2 ,3 ]
Frey, Norbert [2 ,3 ]
Krohn, Jona Benjamin [2 ,3 ]
机构
[1] Semmelwe Univ, Heart & Vasc Ctr, Budapest, Hungary
[2] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany
[3] Heidelberg Univ, German Ctr Cardiovasc Res DZHK, Partner Site Heidelberg Mannheim, Heidelberg, Germany
来源
关键词
extracellular vesicles; cardiovascular disease; diagnosis; prognosis; therapy; biomarker; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; MYOCARDIAL-INFARCTION; NONINVASIVE BIOMARKER; INTERNATIONAL SOCIETY; MICRORNA SIGNATURES; POSITION STATEMENT; EJECTION FRACTION; HEART-FAILURE; WORKING GROUP;
D O I
10.3389/fcvm.2024.1425159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) ranks among the primary contributors to worldwide mortality. Hence, the importance of constant research on new circulating biomarkers for the improvement of early diagnosis and prognostication of different CVDs and the development and refinement of therapeutic measures is critical. Extracellular vesicles (EV) have a great potential as diagnostic and prognostic markers, as they represent their parent cell by enclosing cell-specific molecules, which can differ in quality and quantity based on cell state. Assuming that all cell types of the cardiovascular system are capable of releasing EV into circulation, an emerging body of evidence has investigated the potential role of serum- or plasma-derived EV in CVD. Comprehensive research has unveiled alterations in EV quantity and EV-bound cargo in the form of RNA, proteins and lipids in the context of common CVDs such as coronary artery disease, atrial fibrillation, heart failure or inflammatory heart diseases, highlighting their diagnostic and prognostic relevance. In numerous in vitro and in vivo models, EV also showed promising therapeutic potential. However, translation of EV studies to a preclinical or clinical setting has proven to be challenging. This review is intended to provide an overview of the most relevant studies in the field of serum or plasma-derived EV.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] The Potential Use of Circulating Extracellular Vesicles for Improved Diagnosis and Therapy in Rheumatic Inflammatory/autoimmune Diseases: Proof of Concept Studies
    Halpert, Gilad
    Moskovitch, Ori
    Israel, Linoy
    Govrin, Eri
    Gilburd, Boris
    Segal, Ori
    Anaki, Adi
    Caller, Tal
    Yechiali, Daniel
    Segev, Shlomo
    Gendelman, Omer
    Watad, Abdulla
    Mehrian-Shai, Ruty
    Popovtzer, Rachella
    Amital, Howard
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4550 - 4552
  • [32] Extracellular vesicles: Potential impact on cardiovascular diseases
    Yang, Jian
    Zou, Xue
    Jose, Pedro A.
    Zeng, Chunyu
    ADVANCES IN CLINICAL CHEMISTRY, VOL 105, 2021, 105 : 49 - 100
  • [33] Extracellular vesicles as therapeutic tools in cardiovascular diseases
    Fleury, Audrey
    Martinez, Maria Carmen
    Le Lay, Soazig
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [34] Bioengineering Extracellular Vesicles for the Treatment of Cardiovascular Diseases
    Ramasubramanian, Lalithasri
    Du, Shixian
    Gidda, Siraj
    Bahatyrevich, Nataliya
    Hao, Dake
    Kumar, Priyadarsini
    Wang, Aijun
    ADVANCED BIOLOGY, 2022, 6 (10):
  • [35] Extracellular vesicles: New players in cardiovascular diseases
    Gaceb, Abderahim
    Martinez, Maria Carmen
    Andriantsitohaina, Ramaroson
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 50 : 24 - 28
  • [36] Engineered extracellular vesicles and their mimics in cardiovascular diseases
    Lai, Jialin
    Huang, Chaobo
    Guo, Yuxuan
    Rao, Lang
    JOURNAL OF CONTROLLED RELEASE, 2022, 347 : 27 - 43
  • [37] Review: Multiplexed profiling of biomarkers in extracellular vesicles for cancer diagnosis and therapy monitoring
    Zhou, Sisi
    Yang, Yao
    Wu, Yafeng
    Liu, Songqin
    ANALYTICA CHIMICA ACTA, 2021, 1175
  • [38] CIRCULATING EXTRACELLULAR VESICLES AND SPHINGOLIPIDS CARGO ARE HIGHLY ACCURATE NOVEL BIOMARKERS FOR DIAGNOSIS OF ALCOHOLIC HEPATITIS
    Sehrawat, Tejasav
    Arab, Juan Pablo
    Simonetto, Douglas
    Sanyal, Arun J.
    Chalasani, Naga P.
    Gores, Gregory J.
    Kamath, Patrick S.
    Shah, Vijay
    Malhi, Harmeet
    GASTROENTEROLOGY, 2019, 156 (06) : S98 - S98
  • [39] Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors
    Femmino, Saveria
    Penna, Claudia
    Margarita, Sara
    Comita, Stefano
    Brizzi, Maria F.
    Pagliaro, Pasquale
    VASCULAR PHARMACOLOGY, 2020, 135
  • [40] Extracellular Vesicles as Biomarkers in Cardiovascular Disease; Chances and Risks
    Dickhout, Annemiek
    Koenen, Rory R.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5